These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 14631251)

  • 1. [Cutaneous adverse drug reaction with pulmonary involvement].
    Wolkenstein P; Chosidow O
    Rev Mal Respir; 2003 Nov; 20(5 Pt 1):719-26. PubMed ID: 14631251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Life-threatening acute adverse cutaneous drug reactions.
    Wolf R; Orion E; Marcos B; Matz H
    Clin Dermatol; 2005; 23(2):171-81. PubMed ID: 15802211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug rash with eosinophilia and systemic symptoms vs toxic epidermal necrolysis: the dilemma of classification.
    Wolf R; Matz H; Marcos B; Orion E
    Clin Dermatol; 2005; 23(3):311-4. PubMed ID: 15896547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking.
    Walsh SA; Creamer D
    Clin Exp Dermatol; 2011 Jan; 36(1):6-11. PubMed ID: 21143513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Toxic epidermal necrolysis and Stevens-Johnson syndrome].
    Roujeau JC
    Rev Prat; 2007 Jun; 57(11):1165-70. PubMed ID: 17691257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cutaneous side effects due to psychiatric drugs].
    Rebok F; Pérez Roldán ML; Daray FM
    Vertex; 2008; 19(82):348-56. PubMed ID: 19424517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug-induced lung diseases].
    Medici TC; Fontana A
    Schweiz Med Wochenschr; 1977 Feb; 107(6):162-71. PubMed ID: 13491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two cases of pustular toxic epidermal necrolysis.
    Hague JS; Kaur MR; Hafiji J; Carr RA; Lewis H; Charles-Holmes R; Heagerty A; Orpin SD
    Clin Exp Dermatol; 2011 Jan; 36(1):42-5. PubMed ID: 20497187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan.
    Chiou CC; Yang LC; Hung SI; Chang YC; Kuo TT; Ho HC; Hu S; Hong HS; Chung WH
    J Eur Acad Dermatol Venereol; 2008 Sep; 22(9):1044-9. PubMed ID: 18627428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Toxic epidermal necrolysis].
    Bygum A; Andersen KE
    Ugeskr Laeger; 2006 Aug; 168(33):2645-9. PubMed ID: 16942680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug rash with eosinophilia and systemic symptoms (DRESS syndrome)].
    Lobo I; Ferreira M; Velho G; Sanches M; Selores M
    Acta Med Port; 2008; 21(4):367-72. PubMed ID: 19094812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe drug-induced skin reactions: clinical pattern, diagnostics and therapy.
    Mockenhaupt M
    J Dtsch Dermatol Ges; 2009 Feb; 7(2):142-60; quiz 161-2. PubMed ID: 19371237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular manifestations and complications of Stevens-Johnson syndrome and toxic epidermal necrolysis: an Asian series.
    Yip LW; Thong BY; Lim J; Tan AW; Wong HB; Handa S; Heng WJ
    Allergy; 2007 May; 62(5):527-31. PubMed ID: 17313402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary disorders induced by monoclonal antibodies in patients with rheumatologic autoimmune diseases.
    Ramos-Casals M; Perez-Alvarez R; Perez-de-Lis M; Xaubet A; Bosch X;
    Am J Med; 2011 May; 124(5):386-94. PubMed ID: 21531225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe cutaneous adverse reactions to drugs.
    Chia FL; Leong KP
    Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):304-9. PubMed ID: 17620821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Gueudry J; Roujeau JC; Binaghi M; Soubrane G; Muraine M
    Arch Dermatol; 2009 Feb; 145(2):157-62. PubMed ID: 19221260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical heterogeneity of drug hypersensitivity.
    Roujeau JC
    Toxicology; 2005 Apr; 209(2):123-9. PubMed ID: 15767024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxic epidermal necrolysis caused by flurazepam?
    Loncar C; Franić T; Bilusić M
    Psychiatr Danub; 2005 Dec; 17(3-4):236-9. PubMed ID: 16392434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The variable clinical picture of drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms in relation to the eliciting drug.
    Kano Y; Shiohara T
    Immunol Allergy Clin North Am; 2009 Aug; 29(3):481-501. PubMed ID: 19563993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying prognostic factors for drug rash with eosinophilia and systemic symptoms (DRESS).
    Wei CH; Chung-Yee Hui R; Chang CJ; Ho HC; Yang CH; Lin YJ; Chung WH
    Eur J Dermatol; 2011; 21(6):930-7. PubMed ID: 21951554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.